Director/PDMR Shareholding

Hutchison China Meditech Limited
22 May 2007





                  Hutchison China MediTech Limited ('Chi-Med')

                                   (AIM: HCM)



                            Director's Shareholding



London: Tuesday, 22 May 2007: Chi-Med was informed on 18 May 2007 that Mr.
Christian Hogg, Executive Director and Chief Executive Officer of Chi-Med,
purchased 70,000 ordinary shares of US$1 each in Chi-Med (the 'Shares') at a
price of 153p each on 18 May 2007.



Following this purchase, Mr. Hogg is beneficially interested in 170,000 Shares
and vested option to subscribe for up to 384,091 Shares, representing
approximately 1.1% of the current issued share capital of Chi-Med.



                                      Ends



Enquiries


Chi-Med                            Telephone: [phone]



Christian Hogg, CEO

Citigate Dewe Rogerson             Telephone: [phone]



Anthony Carlisle                   Mobile: [phone]

Yvonne Alexander                   Mobile: [phone]



About Chi-Med



Chi-Med is the holding company of a pharmaceutical and healthcare group based
primarily in China and was admitted to trading on the Alternative Investment
Market of the London Stock Exchange in May 2006.  Chi-Med is focused on
researching, developing, manufacturing, and selling pharmaceuticals, health
supplements and other consumer health and personal care products derived from
Traditional Chinese Medicine and botanical ingredients.



Chi-Med is majority owned by Hutchison Whampoa Limited, an international
corporation listed on the Main Board of The Stock Exchange of Hong Kong Limited.


                      This information is provided by RNS
            The company news service from the London Stock Exchange